Étiquette : ImpriMed

ImpriMed Launches Innovative AI-Driven Drug Response Predictions (DRP) Service to Guide Tailored Treatments, Meet Rising Demand in Veterinary Oncology

ImpriMed Launches Innovative AI-Driven Drug Response Predictions (DRP) Service to Guide Tailored Treatments, Meet Rising Demand in Veterinary Oncology Delivering personalized anticancer treatment predictions, new

28 mai 2024

Two new clinical studies indicate that ImpriMed’s artificial intelligence (AI) algorithms have successfully identified chemotherapy drugs with prospective clinical efficacy in oncology practices throughout US

The ImpriMed Personalized Prediction Profile for dogs with lymphoid malignancies provides clinical outcome predictions for different chemotherapy treatment options (Fig. 1)1,2. Predictions for individual drug

8 février 2024

How AI Can Help Treat (and Cure) Your Dog’s Cancer

A tech startup wants to use AI to help veterinarians give targeted drugs for a dog’s cancer treatment—but is it a helpful tool or are

30 janvier 2024